{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:15:09Z","timestamp":1788516909801,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-63436-9","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:45:28Z","timestamp":1785127528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Developing a prognostic signature with cancer-associated fibroblasts for predicting the prognosis and immune landscape of prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Mei","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangshu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-2668","authenticated-orcid":false,"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"5","key":"63436_CR1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1053\/j.semnuclmed.2024.05.003","volume":"55","author":"A Dullea","year":"2025","unstructured":"Dullea, A. et al. Diagnostic accuracy of 18F-prostate specific membrane antigen (PSMA) PET\/CT radiotracers in staging and restaging of patients with high-risk prostate cancer or biochemical recurrence: An overview of reviews. Semin. Nucl. Med. 55(5), 680\u2013700 (2025).","journal-title":"Semin. Nucl. Med."},{"issue":"2","key":"63436_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","volume":"27","author":"ND Shore","year":"2024","unstructured":"Shore, N. D. et al. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification[J]. Prostate Cancer Prostatic Dis. 27 (2), 192\u2013201 (2024).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"2","key":"63436_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eururo.2024.05.005","volume":"86","author":"IMJ Thompson","year":"2024","unstructured":"Thompson, I. M. J. Prostate-specific antigen screening in limbo: How low should we go?. Eur. Urol. 86(2), 101\u2013102 (2024).","journal-title":"Eur. Urol."},{"issue":"22","key":"63436_CR4","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/0008-5472.CAN-24-0932","volume":"84","author":"H Song","year":"2024","unstructured":"Song, H. et al. YAP1 inhibition induces phenotype switching of cancer-associated fibroblasts to tumor suppressive in prostate cancer. Cancer Res. 84(22), 3728\u20133742 (2024).","journal-title":"Cancer Res."},{"key":"63436_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jare.2024.12.003","volume":"75","author":"Z Xiong","year":"2025","unstructured":"Xiong, Z. et al. Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer. J. Adv. Res. 75, 663\u2013678 (2025).","journal-title":"J. Adv. Res."},{"issue":"1","key":"63436_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12885-025-13435-2","volume":"25","author":"J Ge","year":"2025","unstructured":"Ge, J. et al. TGF-\u03b2 signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: Unveiling insights and clinical significance. BMC Cancer 25(1), 113. (2025).","journal-title":"BMC Cancer"},{"key":"63436_CR7","doi-asserted-by":"publisher","first-page":"1221532","DOI":"10.3389\/fimmu.2023.1221532","volume":"14","author":"RA O\u2019Connor","year":"2023","unstructured":"O\u2019Connor, R. A. et al. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta[J]. Front. Immunol. 14, 1221532 (2023).","journal-title":"Front. Immunol."},{"key":"63436_CR8","doi-asserted-by":"crossref","unstructured":"Padeznik, T. et al. Changes in the Extracellular Matrix in Endometrial and Cervical Cancer: A Systematic Review[J]. Int. J. Mol. Sci. 24(6). (2023).","DOI":"10.3390\/ijms24065463"},{"issue":"1","key":"63436_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"I Elia","year":"2021","unstructured":"Elia, I. & Haigis, M. C. Metabolites and the tumour microenvironment: From cellular mechanisms to systemic metabolism. Nat. Metab. 3(1), 21\u201332 (2021).","journal-title":"Nat. Metab."},{"key":"63436_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier, A. J. & Elsawa, S. F. Macrophage polarization states in the tumor microenvironment. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22136995 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"63436_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","volume":"30","author":"YR Murciano-Goroff","year":"2020","unstructured":"Murciano-Goroff, Y. R., Warner, A. B. & Wolchok, J. D. The future of cancer immunotherapy: Microenvironment-targeting combinations. Cell Res. 30(6), 507\u2013519 (2020).","journal-title":"Cell Res."},{"issue":"2","key":"63436_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen, X. & Cubillos-Ruiz, J. R. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat. Rev. Cancer 21(2), 71\u201388 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"63436_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01835","volume":"10","author":"L Monteran","year":"2019","unstructured":"Monteran, L. & Erez, N. The dark side of fibroblasts: Cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment. Front. Immunol. 10, 1835 (2019).","journal-title":"Front. Immunol."},{"key":"63436_CR14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57243","author":"RL Barrett","year":"2020","unstructured":"Barrett, R. L. & Pure, E. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. Elife https:\/\/doi.org\/10.7554\/eLife.57243 (2020).","journal-title":"Elife"},{"key":"63436_CR15","doi-asserted-by":"crossref","unstructured":"Bonollo, F. et al. The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis[J]. Cancers (Basel) 12(7). (2020).","DOI":"10.3390\/cancers12071887"},{"issue":"7","key":"63436_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41419-022-05086-z","volume":"13","author":"T Wu","year":"2022","unstructured":"Wu, T. et al. Targeting HIC1\/TGF-beta axis-shaped prostate cancer microenvironment restrains its progression[J]. Cell. Death Dis. 13 (7), 624 (2022).","journal-title":"Cell. Death Dis."},{"issue":"12","key":"63436_CR17","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.4049\/jimmunol.177.12.8730","volume":"177","author":"KL Meyer-Siegler","year":"1950","unstructured":"Meyer-Siegler, K. L. et al. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. Journal of immunology (Baltimore, Md.\u202f: 1950) 177(12), 8730\u20138739 (1950).","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"issue":"7","key":"63436_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071625","volume":"14","author":"A Alwhaibi","year":"2022","unstructured":"Alwhaibi, A. et al. Regulation of Let-7a-5p and miR-199a-5p expression by Akt1 modulates prostate cancer epithelial-to-mesenchymal transition via the transforming growth factor-\u03b2 pathway. Cancers 14(7), 1625 (2022).","journal-title":"Cancers"},{"issue":"1","key":"63436_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-36125-0","volume":"13","author":"Y Qian","year":"2023","unstructured":"Qian, Y. et al. Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome. Sci. Rep. 13(1), 9016 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"63436_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42858-9","volume":"13","author":"XY Wen","year":"2023","unstructured":"Wen, X. Y. et al. Integrating single-cell and bulk RNA sequencing to predict prognosis and immunotherapy response in prostate cancer. Sci. Rep. 13(1), 15597 (2023).","journal-title":"Sci. Rep."},{"key":"63436_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1136835","volume":"13","author":"X Zhai","year":"2023","unstructured":"Zhai, X. et al. Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs). Front. Oncol. 13, 1136835 (2023).","journal-title":"Front. Oncol."},{"issue":"1","key":"63436_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell Biol. 23(1), 87\u201398 (2021).","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"63436_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/biostatistics\/kxl028","volume":"8","author":"T Johnson","year":"2007","unstructured":"Johnson, T. Bayesian method for gene detection and mapping, using a case and control design and DNA pooling. Biostatistics 8(3), 546\u2013565 (2007).","journal-title":"Biostatistics"},{"issue":"7","key":"63436_CR24","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res. 43 (7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"63436_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004210","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. A signature for pan-cancer prognosis based on neutrophil extracellular traps. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2021-004210 (2022).","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"63436_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/jnr.20090","volume":"76","author":"CD Mandyam","year":"2004","unstructured":"Mandyam, C. D., Norris, R. D. & Eisch, A. J. Chronic morphine induces premature mitosis of proliferating cells in the adult mouse subgranular zone. J. Neurosci. Res. 76(6), 783\u2013794 (2004).","journal-title":"J. Neurosci. Res."},{"issue":"30","key":"63436_CR27","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32(30), 5381\u20135397 (2013).","journal-title":"Stat. Med."},{"issue":"11","key":"63436_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A. et al. Maftools: Efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28(11), 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"63436_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"63436_CR30","first-page":"78","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. Reshaping and aggregating data: an introduction to reshape package[J]. Ann. Transl Med. 4 (4), 78 (2016).","journal-title":"Ann. Transl Med."},{"issue":"12","key":"63436_CR31","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1158\/2159-8290.CD-20-0522","volume":"10","author":"D Sha","year":"2020","unstructured":"Sha, D. et al. Tumor mutational burden as a predictive biomarker in solid tumors. Cancer Discov. 10(12), 1808\u20131825 (2020).","journal-title":"Cancer Discov."},{"key":"63436_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. OncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab260 (2021).","journal-title":"Brief Bioinform."},{"issue":"11","key":"63436_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000217","volume":"4","author":"E Lee","year":"2008","unstructured":"Lee, E. et al. Inferring pathway activity toward precise disease classification. PLoS Comput. Biol. 4(11), e1000217 (2008).","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"63436_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","volume":"17","author":"Y Senbabaoglu","year":"2016","unstructured":"Senbabaoglu, Y. et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures[J]. Genome Biol. 17 (1), 231 (2016).","journal-title":"Genome Biol."},{"issue":"6282","key":"63436_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq[J]. Science 352 (6282), 189\u2013196 (2016).","journal-title":"Science"},{"key":"63436_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giy083","author":"L Zappia","year":"2018","unstructured":"Zappia, L. & Oshlack, A. Clustering trees: A visualization for evaluating clusterings at multiple resolutions. Gigascience https:\/\/doi.org\/10.1093\/gigascience\/giy083 (2018).","journal-title":"Gigascience"},{"key":"63436_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-356","volume":"14","author":"Y Hu","year":"2000","unstructured":"Hu, Y. et al. Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: A retrospective population-based cohort study, 2000\u20132009. BMC Public Health 14, 356 (2000).","journal-title":"BMC Public Health"},{"issue":"1","key":"63436_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp, M. B. et al. Recent global patterns in prostate cancer incidence and mortality rates. Eur. Urol. 77(1), 38\u201352 (2020).","journal-title":"Eur. Urol."},{"issue":"1","key":"63436_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13099-023-00554-z","volume":"15","author":"C Lin","year":"2023","unstructured":"Lin, C. et al. Single-cell RNA sequencing reveals the mediatory role of cancer-associated fibroblast PTN in hepatitis B virus cirrhosis-HCC progression. Gut Pathog. 15(1), 26. (2023).","journal-title":"Gut Pathog."},{"key":"63436_CR40","first-page":"350","volume":"24","author":"T Wang","year":"2019","unstructured":"Wang, T. et al. Topological methods for visualization and analysis of high dimensional single-cell RNA sequencing data. Pac. Symp. Biocomput. 24, 350\u2013361 (2019).","journal-title":"Pac. Symp. Biocomput."},{"issue":"8","key":"63436_CR41","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada, E. et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 9(8), 1102\u20131123 (2019).","journal-title":"Cancer Discov."},{"issue":"8","key":"63436_CR42","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/cas.14537","volume":"111","author":"R Kanzaki","year":"2020","unstructured":"Kanzaki, R. & Pietras, K. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine. Cancer Sci. 111(8), 2708\u20132717 (2020).","journal-title":"Cancer Sci."},{"key":"63436_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fcell.2020.00159","volume":"8","author":"MA Russell","year":"2020","unstructured":"Russell, M. A. Synemin Redefined: Multiple Binding Partners Results in Multifunctionality[J]. Front. Cell. Dev. Biol. 8, 159 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"3","key":"63436_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108284","volume":"33","author":"L He","year":"2020","unstructured":"He, L. et al. A regulation loop between YAP and NR4A1 balances cell proliferation and apoptosis. Cell Rep. 33(3), 108284 (2020).","journal-title":"Cell Rep."},{"issue":"3","key":"63436_CR45","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/pros.21059","volume":"70","author":"HC Whitaker","year":"2010","unstructured":"Whitaker, H. C. et al. The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target[J]. Prostate 70 (3), 333\u2013340 (2010).","journal-title":"Prostate"},{"key":"63436_CR46","doi-asserted-by":"crossref","unstructured":"Caspa, G. R., Yap, L. F. & Paterson, I. C. H. O. P. X. A Unique Homeodomain Protein in Development and Tumor Suppression[J]. Cancers (Basel) 14(11). (2022).","DOI":"10.3390\/cancers14112764"},{"issue":"5","key":"63436_CR47","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.hrthm.2020.12.033","volume":"18","author":"RG Li","year":"2021","unstructured":"Li, R. G. et al. Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease. Heart Rhythm 18(5), 684\u2013693 (2021).","journal-title":"Heart Rhythm"},{"issue":"1","key":"63436_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02137-7","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang, J. & Sun, P. Identification of GJC1 as a novel diagnostic marker for papillary thyroid carcinoma using weighted gene co-expression network analysis and machine learning algorithm. Discov. Oncol. 16(1), 339 (2025).","journal-title":"Discov. Oncol."},{"key":"63436_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1440409","volume":"18","author":"X Ji","year":"2024","unstructured":"Ji, X. et al. Discovery of GJC1 as a prognostic biomarker in glioma cells: Insights into its cell-cycle relationship and differential expression in non-neuronal cells. Front. Cell. Neurosci. 18, 1440409 (2024).","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"63436_CR50","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/jcp.26803","volume":"234","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. High glucose stimulates proliferative capacity of liver cancer cells possibly via O-GlcNAcylation-dependent transcriptional regulation of GJC1. J. Cell. Physiol. 234(1), 606\u2013618 (2018).","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"63436_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.eururo.2025.01.010","volume":"87","author":"AA Azad","year":"2025","unstructured":"Azad, A. A. et al. Combination therapies in locally advanced and metastatic hormone-sensitive prostate cancer. Eur. Urol. 87(4), 455\u2013467 (2025).","journal-title":"Eur. Urol."},{"issue":"1","key":"63436_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaoncol.2025.4800","volume":"12","author":"NG Zaorsky","year":"2026","unstructured":"Zaorsky, N. G. et al. Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis[J]. JAMA Oncol. 12 (1), 58\u201365 (2026).","journal-title":"JAMA Oncol."},{"issue":"1","key":"63436_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.eururo.2025.09.007","volume":"89","author":"IB Riaz","year":"2026","unstructured":"Riaz, I. B. et al. Comparative survival in metastatic hormone-sensitive prostate cancer by volume of disease and timing of metastasis: A living network meta-analysis. Eur. Urol. 89(1), 31\u201344 (2026).","journal-title":"Eur. Urol."},{"issue":"3","key":"63436_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ady5324","volume":"12","author":"D Zhao","year":"2026","unstructured":"Zhao, D. et al. Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer. Sci. Adv. 12(3), eady5324 (2026).","journal-title":"Sci. Adv."},{"issue":"9","key":"63436_CR55","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1111\/cas.16267","volume":"115","author":"S Pan","year":"2024","unstructured":"Pan, S. et al. Prostate cancer cancer-associated fibroblasts with stable markers post-androgen deprivation therapy associated with tumor progression and castration resistant prostate cancer. Cancer Sci. 115(9), 2893\u20132907 (2024).","journal-title":"Cancer Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63436-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63436-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63436-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:40:52Z","timestamp":1788514852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63436-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63436"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63436-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data in this study were obtained from public databases; clinical ethics approval is not required.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27782"}}